Cite
MLA Citation
E. Paszkiewicz‐Kozik et al.. “OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8).” Hematological oncology, vol. 37, n.d., pp. 436–437. http://access.bl.uk/ark:/81055/vdc_100086208697.0x00003c